Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10155)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2014 (publication date) through Apr 19, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Loc WS, Smith JP, Matters G, Kester M, Adair JH. Novel strategies for managing pancreatic cancer. World J Gastroenterol 2014; 20(40): 14717-14725 [PMID: 25356034 DOI: 10.3748/wjg.v20.i40.14717] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i40/14717.htm |
| Number | Citing Articles |
| 1 |
Yen-Yi Juo, Melinda A. Maggard Gibbons, Erik Dutson, Anne Y. Lin, Jane Yanagawa, O. Joe Hines, Guido Eibl, Yijun Chen. Obesity Is Associated with Early Onset of Gastrointestinal Cancers in California. Journal of Obesity 2018; 2018: 1 doi: 10.1155/2018/7014073
|
| 2 |
Lei Wang, Jianwei Xu, Ye Yan, Han Liu, Thiruventhan Karunakaran, Feng Li.
Green synthesis of gold nanoparticles from
Scutellaria barbata
and its anticancer activity in pancreatic cancer cell (PANC‐1)
. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 1617 doi: 10.1080/21691401.2019.1594862
|
| 3 |
Ramesh Pothuraju, Satyanarayana Rachagani, Wade M. Junker, Sanjib Chaudhary, Viswanathan Saraswathi, Sukhwinder Kaur, Surinder K. Batra. Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0963-4
|
| 4 |
|
| 5 |
Jinming Yu, Zhaoyan Ding, Yuanming Yang, Shanli Liu. Increased platelet-to-lymphocytes ratio is associated with poor long-term prognosis in patients with pancreatic cancer after surgery. Medicine 2018; 97(25): e11002 doi: 10.1097/MD.0000000000011002
|
| 6 |
Ming-Hsien Chien, Tzong-Huei Lee, Wei-Jiunn Lee, Yen-Hsiu Yeh, Tsai-Kun Li, Po-Chuan Wang, Jih-Jung Chen, Jyh-Ming Chow, Yung-Wei Lin, Michael Hsiao, Shih-Wei Wang, Kuo-Tai Hua. Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenografts. Cancer Letters 2017; 388: 249 doi: 10.1016/j.canlet.2016.12.002
|
| 7 |
Isabelle Ribeiro BARBOSA, Camila Alves dos SANTOS, Dyego Leandro Bezerra de SOUZA. PANCREATIC CANCER IN BRAZIL: MORTALITY TRENDS AND PROJECTIONS UNTIL 2029. Arquivos de Gastroenterologia 2018; 55(3): 230 doi: 10.1590/s0004-2803.201800000-59
|
| 8 |
Miho Akimoto, Mari Iizuka, Rie Kanematsu, Masato Yoshida, Keizo Takenaga, Guillermo Velasco. Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death. PLOS ONE 2015; 10(5): e0126605 doi: 10.1371/journal.pone.0126605
|
| 9 |
Keizo Takenaga, Miho Akimoto, Nobuko Koshikawa, Hiroki Nagase, Sulagna Banerjee. Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model. PLOS ONE 2020; 15(4): e0232230 doi: 10.1371/journal.pone.0232230
|
| 10 |
Hosein Esmaeili, Mehrdad Nasrollahzadeh Sabet, Reza Mosaed, Mohsen Chamanara, Saeid Hadi, Ebrahim Hazrati, Arezoo Farhadi, Mohammad Foad Heidari, Javad Behroozi. Oleanolic acid increases the anticancer potency of doxorubicin in pancreatic cancer cells. Journal of Biochemical and Molecular Toxicology 2023; 37(10) doi: 10.1002/jbt.23426
|
| 11 |
Laszlo Czako. Pancreatic Carcinoma and Diabetes Mellitus. Gastroenterology & Hepatology: Open Access 2017; 6(4) doi: 10.15406/ghoa.2017.06.00203
|
| 12 |
Miho Akimoto, Riruke Maruyama, Yasunari Kawabata, Yoshitsugu Tajima, Keizo Takenaga. Antidiabetic adiponectin receptor agonist AdipoRon suppresses tumour growth of pancreatic cancer by inducing RIPK1/ERK-dependent necroptosis. Cell Death & Disease 2018; 9(8) doi: 10.1038/s41419-018-0851-z
|
| 13 |
M. Tempero, D.-Y. Oh, J. Tabernero, M. Reni, E. Van Cutsem, A. Hendifar, D.-T. Waldschmidt, N. Starling, J.-B. Bachet, H.-M. Chang, J. Maurel, R. Garcia-Carbonero, S. Lonardi, L.M. Coussens, L. Fong, L.C. Tsao, G. Cole, D. James, T. Macarulla. Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study. Annals of Oncology 2021; 32(5): 600 doi: 10.1016/j.annonc.2021.01.070
|
| 14 |
|